Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
| MNBIX Fund | USD 20.50 0.18 0.89% |
Slightly above 51% of Pro Blend's investor base is interested to short. The analysis of overall sentiment of trading Pro Blend Extended Term mutual fund suggests that many investors are impartial at this time. Pro Blend's investing sentiment can be driven by a variety of factors including economic data, Pro Blend's earnings reports, geopolitical events, and overall market trends.
Pro |
Novartis has entered into an exclusive license and collaboration agreement with Ratio Therapeutics for the development of a SSTR2 radiotherapeutic candidate for cancer.
Read at seekingalpha.com
 |
Pro Blend Fundamental Analysis
We analyze Pro Blend's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pro Blend using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pro Blend based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Pro Blend is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Pro Blend Extended Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pro Blend mutual fund to make a market-neutral strategy. Peer analysis of Pro Blend could also be used in its relative valuation, which is a method of valuing Pro Blend by comparing valuation metrics with similar companies.
Peers
Pro Blend Related Equities
| THQ | Tekla Healthcare | 2.37 | ||||
| AHSCX | Alger Health | 0.67 | ||||
| LOGSX | Live Oak | 0.46 | ||||
| HIAHX | Hartford Healthcare | 0.29 | ||||
| GGHYX | Invesco Global | 0.05 |
Other Information on Investing in Pro Mutual Fund
Pro Blend financial ratios help investors to determine whether Pro Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pro with respect to the benefits of owning Pro Blend security.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |